Email
Password
Remember meForgot password?
    Log in with Twitter

branded drug News

Op-Ed: Mylan's $465 million EpiPen settlement to Medicaid is laughable

Drug-maker Mylan has agreed to pay $465 million to settle allegations that it over-billed Medicaid for its life-saving EpiPen, all without their admitting any guilt, and closing the book on a federal investigation.
 

Search Digital Journal Archives


Set up a news alert for

branded drug


branded drug Image


Latest News
Top News